• SENSEX 81,811.84
    -596.33 (--0.72%)
  • BANKNIFTY 56,252.85
    675.40 (+1.22%)
  • Dixon Technolog.
    14,550.00 19,149.80(%)
  • Kerala Ayurveda
    511.70 515.00(%)
  • Mazagon Dock
    3,358.00 3,778.00(%)
  • Garden Reach Sh.
    3,450.00 3,528.00(%)
  • Bank of Maha
    53.01 38.11(%)
  • Ola Electric
    43.20 45.06(%)
  • Zee Entertainmen
    146.80 163.90(%)
  • Bharat Electron
    420.50 410.00(%)
  • Cochin Shipyard
    2,244.00 2,977.10(%)
  • Trent
    6,105.30 8,345.85(%)
  • Waaree Energies
    2,927.75 1,808.65(%)
  • Apollo Micro Sys
    214.50 211.60(%)
  • Paras Defence
    1,739.85 1,943.60(%)
  • Aeroflex
    212.20 271.60(%)
  • Northern ARC
    235.80 351.00(%)
  • Zen Technologies
    1,995.30 2,627.95(%)
  • TCS
    3,370.10 3,060.25(%)
  • Multi Comm. Exc.
    8,247.20 8,108.35(%)
  • Swiggy
    394.40 617.00(%)
  • Suzlon Energy
    62.10 46.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kimia Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4940.0
  • ISIN : INE285U01025
47.00 1 (3.18%)
  • As on 23 Jun 2025 (EOD)

  • Today’s Low

    44.64

  • Today’s High

    47.50

  • Open

    44.64

  • Perv Close

    45.55

  • 52W Low

    35.10

  • 52W High

    58.39

Key Indicators

  • P/E(TTM)

    23.15

  • Mar.Cap (₹Cr.)

    222.37

  • Div & Yield %

    0.00

  • Book Value(₹)

    2.11

  • Debt-Equity Ratio

    3.18

  • AGM Date

    20-Jun-2025

  • EPS

    2.03

  • P/E Ratio

    23.15

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    222.37

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.73

  • BV (₹)

    2.10

  • Sales( ₹ in Cr.)

    118.92

  • NP (in Cr.)

    9.61

  • NP Var(%)

    281.0

  • Div%

    0.0

  • CPS (₹)

    2.70

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    222.37

  • 52 Week High

    58.39

  • 52 Week Low

    35.10

  • Price BSE

    47.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    222.37

  • P/C Ratio

    17.10

  • P/E Ratio

    23.10

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 104.88 128.52 124.90 132.71 106.29 93.92
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 104.88 128.52 124.90 132.71 106.29 93.92
Other Income 1.64 1.21 0.93 2.46 0.96 1.33
Stock Adjustments -7.90 10.36 3.77 6.27 -1.15 1.14
Total Income 98.62 140.09 129.60 141.44 106.10 96.39
EXPENDITURE :            
Raw Materials 67.36 106.39 96.03 103.13 79.09 72.22
Power and Fuel Cost 5.25 7.29 6.54 4.54 3.21 2.54
Employee Cost 15.15 16.40 15.08 14.09 10.80 8.82
Other Manufacturing Expenses 1.93 2.93 2.40 2.64 1.74 1.08
Selling and Administration Expenses 6.30 7.04 6.16 4.88 3.76 2.33
Miscellaneous Expenses 1.47 4.85 1.82 1.33 2.08 2.50
Employee Benefit Expenses 15.15 16.40 15.08 14.09 10.80 8.82
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 97.46 144.90 128.04 130.61 100.68 89.48
Operating Profit 1.16 -4.81 1.56 10.84 5.42 6.90
Interest 5.05 4.25 3.64 3.39 2.53 2.00
Gross Profit -3.89 -9.06 -2.08 7.45 2.89 4.90
Depreciation 3.29 3.33 2.94 1.91 1.66 1.10
Profit Before Tax -7.18 -12.39 -5.02 5.54 1.23 3.80
Current Tax 0.00 0.00 0.00 0.00 -0.16 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.88 -3.04 -1.32 0.43 0.00 -0.05
Reported Net Profit -5.31 -9.35 -3.70 5.10 1.38 3.86
Extraordinary Items 0.00 -1.05 0.08 0.07 -0.01 0.02
Adjusted Net Profit -5.31 -8.30 -3.78 5.03 1.39 3.84
Adjustment below Net Profit 0.18 -0.07 0.16 -0.04 0.00 0.00
P & L Balance brought forward -5.35 4.07 7.62 2.56 1.23 -2.62
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -10.49 -5.35 4.07 7.62 2.61 1.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -1.12 -1.98 -0.78 1.08 0.30 2.64
Earnings Per Share(Adj)-Unit Curr -1.12 -1.98 -0.78 1.08 0.30 2.64
Book Value 0.07 1.15 3.15 3.90 2.86 2.39
Book Value(Adj)-Unit Curr 0.07 1.15 3.15 3.90 2.86 2.39

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 35,455,840 74.94 35,455,840 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 35,455,840 74.94 35,455,840 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 181,100 0.38 0 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 181,100 0.38 0 3
2] Non Institution
Bodies Corporate 105,617 0.22 21,617 40
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 521,726 1.10 106,626 191
Foreign Non Institution Other 100,000 0.21 0 1
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,052,108 17.02 8,052,108 4
Individuals holding nominal share capital up to Rs. 1 lakh 2,849,842 6.02 1,205,642 11,994
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 46,508 0.10 45,908 41
Sub Total 11,675,801 24.68 9,431,901 12,271
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 47,312,741 100.00 44,887,741 12,278

Company Background

Kimia Biosciences LtdPharmaceuticals - Indian - Bulk Drugs

  • Kimia Biosciences Ltd
  • BSE Code : 4940.0
  • ISIN : INE285U01025

  • Incorporation Year

    1993

  • Registered Office

    Bhondsi Village
    Tehsil Sohna, Gurgaon,
    Haryana-122102

  • Telephone

    91-11-29535650

  • FAX

  • Chairman

    Sameer Goel

  • Managing Director

  • Company Secretary

    Pallavi Garg

  • Auditor

    Singhi & Co/Sunil Suresh & Associates

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    Beetal Fin.&Computer Ser.P Ltd
    Beetal House 3rd Flr,
    Behind Local Shp Cen,Nr Dada Harsukh Das
    Mumbai - New Delhi - 110062

Kimia Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kimia Bioscien. 47.00 106.52 104.88 23.15 0.00
Abbott India 31,529.10 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,883.00 1,330.33 1,295.53 191.86 33.26
P & G Health Ltd 5,891.05 1,166.89 1,151.26 38.93 39.76
Glaxosmi. Pharma 3,205.20 3,866.05 3,723.49 59.08 58.72
Cipla 1,500.50 17,645.00 16,574.34 23.50 20.10
Amrutanjan Healt 724.00 437.58 421.23 41.18 20.84
Guj. Themis Bio. 321.05 174.19 169.82 71.66 44.82
Fermenta Biotec. 315.30 315.24 307.09 13.73 4.10
Bliss GVS Pharma 138.25 638.96 605.46 21.11 11.19
Ambalal Sarabhai 35.59 11.70 3.81 32.95 1.92